Skip to main content

MARSHALL WACE, LLP

Position in KROS — Keros Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in KROS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$370,220
-$2,155,825 QoQ
Shares Held
34,600
-20.5% QoQ
Ownership
0.175%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 131 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in KROS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. KROS ranks #226 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KROS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $370,220 34,600
2024-09-30 $2,526,045 43,500
2024-06-30 $1,022,628 22,377
2024-03-31 $18,070,680 272,971
2023-12-31 $1,967,006 49,472
2023-06-30 $2,517,277 62,650
2023-03-31 $4,975,404 116,520
2022-12-31 $307,328 6,400
2022-06-30 $1,462,566 52,934
2022-03-31 $406,109 7,468
2021-12-31 $335,086 5,727
2021-09-30 $1,963,600 49,636
2021-06-30 $511,975 12,055
2021-03-31 $361,729 5,877
2020-12-31 $1,233,885 17,492